These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 577497)

  • 21. [In vitro diagnosis of T3 thyrotoxicosis].
    Semenov VD
    Med Radiol (Mosk); 1983 Jun; 28(6):72-5. PubMed ID: 6688114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between serum triiodothyronine and thyroxine concentrations in hyperthyroidism.
    de Rave S; Bravenboer B; Loosveld OJ; Lockefeer JH; Goldschmidt HM
    Neth J Med; 1993 Feb; 42(1-2):48-52. PubMed ID: 8446224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
    Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB
    Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Excessive peripheral conversion of thyroxine (T4) to triiodothyronine (T3) in the pathogenesis of T3-hyperthyroidism (author's transl)].
    Herrmann J; Lehr HJ; Kröll HJ; Rusche HJ; Rudorff KH; Krüskemper HL
    Dtsch Med Wochenschr; 1975 Nov; 100(45):2319-23. PubMed ID: 52434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short and long term effects of radioiodine and antithyroid drugs on T4 binding proteins, free T4 and T3, during Graves' disease therapy.
    Jaffiol C; Baldet L; Robin M; Papachristou C; Lapinski H; Mirouze J
    Horm Metab Res; 1977 Jan; 9(1):73-81. PubMed ID: 66177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease.
    Amino N; Yabu Y; Miyai K; Fujie T; Azukizawa M; Onishi T; Kumahara Y
    Lancet; 1978 Aug; 2(8085):344-6. PubMed ID: 79711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in serum TSH and T4 after T3 suppression tests in patients treated for hyperthyroidism due to Graves' disease.
    Suematsu H; Tamai H; Esaki M; Kurokawa N; Aoki H; Matsuzuka F; Miyauchi A; Kuma K
    J Clin Endocrinol Metab; 1977 Nov; 45(5):1013-8. PubMed ID: 579181
    [No Abstract]   [Full Text] [Related]  

  • 29. Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis.
    Izumi M; Larsen PR
    Metabolism; 1978 Apr; 27(4):449-60. PubMed ID: 580305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of simultaneous T3, T4, and TSH measurements for management of graves' disease in children.
    Golden MP; Kaplan SA; Lippe BM; Lee WN
    Pediatrics; 1977 May; 59(5):762-7. PubMed ID: 577011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.
    Yoshimura Noh J; Momotani N; Fukada S; Ito K; Miyauchi A; Amino N
    Endocr J; 2005 Oct; 52(5):537-42. PubMed ID: 16284430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The toxic effect of small iodine supplements in patients with autonomous thyroid nodules.
    Livadas DP; Koutras DA; Souvatzoglou A; Beckers C
    Clin Endocrinol (Oxf); 1977 Aug; 7(2):121-7. PubMed ID: 890996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High levels of serum soluble interleukin-2 receptors in hyperthyroid patients: correlation with serum thyroid hormones and independence from the etiology of the hyperthyroidism.
    Koukkou E; Panayiotidis P; Alevizou-Terzaki V; Thalassinos N
    J Clin Endocrinol Metab; 1991 Oct; 73(4):771-6. PubMed ID: 1909702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum cytokines in thyrotoxicosis.
    Siddiqi A; Monson JP; Wood DF; Besser GM; Burrin JM
    J Clin Endocrinol Metab; 1999 Feb; 84(2):435-9. PubMed ID: 10022397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid function in molar pregnancy.
    Nagataki S; Mizuno M; Sakamoto S; Irie M; Shizume K
    J Clin Endocrinol Metab; 1977 Feb; 44(2):254-63. PubMed ID: 402378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Triiodothyronine thyrotoxicosis in nodular toxic goiter].
    Raskin AM; Alesov VZ; Lebedeva NA; Shlimovich PB
    Probl Endokrinol (Mosk); 1976; 22(3):30-3. PubMed ID: 59358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyrotoxicosis without elevated serum triiodothyronine levels during diabetic ketoacidosis.
    Mayfield RK; Sagel J; Colwell JA
    Arch Intern Med; 1980 Mar; 140(3):408-10. PubMed ID: 6767458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of total thyroxine-binding globulin deficiency with Graves' disease: fluctuations of plasma triiodothyronine/thyroxine ratio.
    Kamikubo K; Kojima N; Yamakita N; Miura K
    Jpn J Med; 1986 May; 25(2):186-90. PubMed ID: 3091890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism.
    Verhoeven RP; Visser TJ; Doctor R; Hennemann G; Schalekamp MA
    J Clin Endocrinol Metab; 1977 May; 44(5):1002-5. PubMed ID: 576870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further studies on the long-term treatment of Graves' hyperthyroidism with ipodate: assessment of a minimal effective dose.
    Shen DC; Wu SY; Chopra IJ; Shian LR; Florsheim W; Solomon DH
    Thyroid; 1991; 1(2):143-6. PubMed ID: 1822359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.